{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:27:02Z","timestamp":1777555622397,"version":"3.51.4"},"reference-count":211,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>Diabetes Technology Society hosted its annual Diabetes Technology Meeting on November 12 to November 14, 2020. This meeting brought together speakers to cover various perspectives about the field of diabetes technology. The meeting topics included artificial intelligence, digital health, telemedicine, glucose monitoring, regulatory trends, metrics for expressing glycemia, pharmaceuticals, automated insulin delivery systems, novel insulins, metrics for diabetes monitoring, and discriminatory aspects of diabetes technology. A live demonstration was presented.<\/jats:p>","DOI":"10.1177\/19322968211016480","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T06:15:44Z","timestamp":1625120144000},"page":"916-960","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes Technology Meeting 2020"],"prefix":"10.1177","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-9336","authenticated-orcid":false,"given":"Trisha","family":"Shang","sequence":"first","affiliation":[{"name":"Diabetes Technology Society, Burlingame, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-9777","authenticated-orcid":false,"given":"Jennifer Y.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Diabetes Technology Society, Burlingame, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-1902","authenticated-orcid":false,"given":"B. Wayne","family":"Bequette","sequence":"additional","affiliation":[{"name":"Rensselaer Polytechnic Institute, Troy, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-4932","authenticated-orcid":false,"given":"Jennifer K.","family":"Raymond","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-9625","authenticated-orcid":false,"given":"Gerard","family":"Cot\u00e9","sequence":"additional","affiliation":[{"name":"Texas A & M University, College Station, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-3043","authenticated-orcid":false,"given":"Jennifer L.","family":"Sherr","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-5374","authenticated-orcid":false,"given":"Jessica","family":"Castle","sequence":"additional","affiliation":[{"name":"Oregon Health Sciences University, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-3269","authenticated-orcid":false,"given":"John","family":"Pickup","sequence":"additional","affiliation":[{"name":"King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yarmela","family":"Pavlovic","sequence":"additional","affiliation":[{"name":"Mannatt, Phelps & Phillips, LLP, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-588X","authenticated-orcid":false,"given":"Juan","family":"Espinoza","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7493-0989","authenticated-orcid":false,"given":"Laurel H.","family":"Messer","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Childhood Diabetes, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8346-2037","authenticated-orcid":false,"given":"Tim","family":"Heise","sequence":"additional","affiliation":[{"name":"Profil, Neuss, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1875-6124","authenticated-orcid":false,"given":"Carlos E.","family":"Mendez","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kim","sequence":"additional","affiliation":[{"name":"University of California San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry H.","family":"Ginsberg","sequence":"additional","affiliation":[{"name":"Diabetes Technology Consultants, Arlington, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3269-804X","authenticated-orcid":false,"given":"Umesh","family":"Masharani","sequence":"additional","affiliation":[{"name":"University of California San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-6862","authenticated-orcid":false,"given":"David C.","family":"Klonoff","sequence":"additional","affiliation":[{"name":"Mills-Peninsula Medical Center, San Mateo, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"bibr1-19322968211016480","unstructured":"Frankenfield J. How artificial intelligence works. Investopedia. Accessed March 25, 2021. https:\/\/www.investopedia.com\/terms\/a\/artificial-intelligence-ai.asp"},{"key":"bibr2-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"bibr3-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11708"},{"key":"bibr4-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1907863"},{"key":"bibr5-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004736"},{"key":"bibr6-19322968211016480","unstructured":"Artificial Intelligence. Wikipedia. 2021. Accessed March 25, 2021. https:\/\/en.wikipedia.org\/w\/index.php?title=Artificial_intelligence&oldid=1013170149"},{"key":"bibr7-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206881"},{"key":"bibr8-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820965561"},{"key":"bibr9-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1045-7"},{"key":"bibr10-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217301"},{"key":"bibr11-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0212-y"},{"key":"bibr12-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2016.07.019"},{"key":"bibr13-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2017.02.014"},{"key":"bibr14-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818761457"},{"key":"bibr15-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820929390"},{"key":"bibr16-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108396"},{"key":"bibr17-19322968211016480","unstructured":"About iPDM. Roche diabetes care. Accessed March 29, 2021. https:\/\/www.rochediabetes.com\/en\/about-ipdm"},{"key":"bibr18-19322968211016480","unstructured":"LifeScan. OneTouch Reveal\n                      \u00ae\n                      mobile app provides insights. Accessed March 30, 2021. https:\/\/www.lifescan.com\/news-and-updates\/2018-press-releases\/onetouch-reveal-app-provides-more-insights"},{"key":"bibr19-19322968211016480","unstructured":"Glooko. Why weare a platform not justan app. Diabetes Remote Monitoring. Population Management. Published May 19, 2016. Accessed March 30, 2021. https:\/\/www.glooko.com\/2016\/05\/platform-not-just-app\/"},{"key":"bibr20-19322968211016480","unstructured":"Virtual Clinic. Onduo.com. Accessed March 30, 2021. https:\/\/onduo.com\/virtualclinic\/"},{"key":"bibr21-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0042"},{"key":"bibr22-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1021\/ac050429e"},{"key":"bibr23-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.8b01429"},{"key":"bibr24-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.210"},{"key":"bibr25-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400503"},{"key":"bibr26-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-018-1395-x"},{"key":"bibr27-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33189-1"},{"key":"bibr28-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0020"},{"key":"bibr29-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820964574"},{"key":"bibr30-19322968211016480","unstructured":"Suri JT. Non-enzymatic electrochemical sensor for measuring analytes. Published online August 3, 2017. Accessed December 15, 2020. https:\/\/patents.google.com\/patent\/US20170219521A1\/en?assignee=glucovation&oq=glucovation"},{"key":"bibr31-19322968211016480","unstructured":"Abbott Diabetes Care. Abbott FreeStyle Libre 2 User Manual. Published 2020. Accessed March 2, 2021. https:\/\/www.manualslib.com\/manual\/1948005\/Abbott-Freestyle-Libre-2.html"},{"key":"bibr32-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0143"},{"key":"bibr33-19322968211016480","unstructured":"Dexcom Provider. Discover Dexcom continuous glucose monitoring (CGM) technology. Accessed December 15, 2020. https:\/\/provider.dexcom.com\/dexcom-cgm"},{"key":"bibr34-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0087"},{"key":"bibr35-19322968211016480","unstructured":"Dexcom. CGM for hospital use: facts. Published April 3, 2020. Accessed March 30, 2021. https:\/\/www.dexcom.com\/hospitalfacts"},{"key":"bibr36-19322968211016480","unstructured":"Abbott\u2019s FreeStyle\n                      \u00ae\n                      Libre 14 day system now available in U.S. for hospitalized patients with diabetes during COVID-19 pandemic. Accessed December 15, 2020. https:\/\/www.prnewswire.com\/news-releases\/abbotts-freestyle-libre-14-day-system-now-available-in-us-for-hospitalized-patients-with-diabetes-during-covid-19-pandemic-301037529.html"},{"key":"bibr37-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820964264"},{"key":"bibr38-19322968211016480","unstructured":"sugarBEAT. Meet sugarBEAT. Accessed January 4, 2021. https:\/\/sugarbeat.com\/"},{"key":"bibr39-19322968211016480","unstructured":"Healthline. SugarBEAT: first no-needles glucose monitor. Published October 25, 2019. Accessed December 15, 2020. https:\/\/www.healthline.com\/diabetesmine\/non-invasive-sugarbeat-cgm-diabetes"},{"key":"bibr40-19322968211016480","unstructured":"Senseonics announces FDA approval for a non-adjunctive indication (dosing claim) for the Eversense\n                      \u00ae\n                      90-day CGM system. Accessed March 30, 2021. https:\/\/www.senseonics.com\/investor-relations\/news-releases\/2019\/06-06-2019-213456270"},{"key":"bibr41-19322968211016480","unstructured":"Senseonics. Home. Accessed March 30, 2021. https:\/\/global.eversensediabetes.com\/"},{"key":"bibr42-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0234"},{"key":"bibr43-19322968211016480","unstructured":"Senseonics Holdings, Inc. Reports, second quarter 2019 financial results. Accessed March 30, 2021. https:\/\/www.senseonics.com\/investor-relations\/news-releases\/2019\/08-07-2019-210738856"},{"key":"bibr44-19322968211016480","unstructured":"Senseonics submits PMA application for 180-day eversense system to the FDA. Accessed March 30, 2021. https:\/\/www.senseonics.com\/investor-relations\/news-releases\/2020\/10-05-2020-123008373"},{"key":"bibr45-19322968211016480","unstructured":"Abbott MediaRoom. Abbott\u2019s FreeStyle\n                      \u00ae\n                      Libre 2 iCGM cleared in U.S. for adults and children with diabetes, achieving highest level of accuracy and performance standards. Accessed April 5, 2021. https:\/\/abbott.mediaroom.com\/2020-06-15-Abbotts-FreeStyle-R-Libre-2-iCGM-Cleared-in-U-S-for-Adults-and-Children-with-Diabetes-Achieving-Highest-Level-of-Accuracy-and-Performance-Standards"},{"key":"bibr46-19322968211016480","unstructured":"Abbott MediaRoom. Abbott\u2019s FreeStyle\n                      \u00ae\n                      Libre 3 system receives CE mark\u2014features world\u2019s smallest, thinnest sensor with best-in-class performance at the same low cost for people with diabetes. Accessed January 28, 2021. https:\/\/abbott.mediaroom.com\/2020-09-28-Abbotts-FreeStyle-R-Libre-3-System-Receives-CE-Mark-Features-Worlds-Smallest-Thinnest-Sensor-with-Best-in-Class-Performance-at-the-Same-Low-Cost-for-People-with-Diabetes"},{"key":"bibr47-19322968211016480","unstructured":"Dexcom Provider. Dexcom G6 pro professional continuous glucose monitoring. Accessed April 5, 2021. https:\/\/provider.dexcom.com\/products\/dexcom-g6-pro"},{"key":"bibr48-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0085"},{"key":"bibr49-19322968211016480","unstructured":"Dexcom G6 continuous glucose monitoring (CGM) system receives CE mark for use during pregnancy in the EU. Published February 20, 2020. Accessed April 5, 2021. https:\/\/www.businesswire.com\/news\/home\/20200220005035\/en\/Dexcom-G6-Continuous-Glucose-Monitoring-CGM-System-Receives-CE-Mark-for-Use-During-Pregnancy-in-the-EU"},{"key":"bibr50-19322968211016480","unstructured":"U.S. Food and Drug Administration. FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. FDA. Published December 13, 2019. Accessed April 12, 2021. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-first-interoperable-automated-insulin-dosing-controller-designed-allow-more-choices"},{"key":"bibr51-19322968211016480","unstructured":"U.S. Food and Drug Administration. Medical device development tools (MDDT). FDA. Published February 23, 2021. Accessed April 12, 2021. https:\/\/www.fda.gov\/medical-devices\/science-and-research-medical-devices\/medical-device-development-tools-mddt"},{"key":"bibr52-19322968211016480","unstructured":"U.S. Food and Drug Administration. MDDT summary of evidence and basis of qualification decision for INSPIRE questionnaires. Published online November 22, 2019. https:\/\/www.fda.gov\/media\/139432\/download"},{"key":"bibr53-19322968211016480","unstructured":"U.S. Food and Drug Administration. MiniMed 770G system\u2014P160017\/S076. Published online December 23, 2020. Accessed April 12, 2021. https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/minimed-770g-system-p160017s076"},{"key":"bibr54-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814551046"},{"key":"bibr55-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0416"},{"key":"bibr56-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12854"},{"key":"bibr57-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819838525"},{"key":"bibr58-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0434"},{"key":"bibr59-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0236"},{"key":"bibr60-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0034"},{"key":"bibr61-19322968211016480","unstructured":"Inkwood Research. Global glucose monitoring market forecast 2019-2027. Published June 2019. Accessed April 14, 2021. https:\/\/www.reportlinker.com\/p05067731\/GLOBAL-GLUCOSE-MONITORING-SYSTEM-CGMS-SMBG-MARKET-FORECAST.html?utm_source=PRN"},{"key":"bibr62-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3430"},{"key":"bibr63-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db20-851-P"},{"key":"bibr64-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1561"},{"key":"bibr65-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400309"},{"key":"bibr66-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818768834"},{"key":"bibr67-19322968211016480","unstructured":"PubMed. Effect of BGM accuracy on the clinical performance of CGM: an in-silico study. Accessed April 14, 2021. https:\/\/pubmed.ncbi.nlm.nih.gov\/28560900\/"},{"key":"bibr68-19322968211016480","unstructured":"Dexcom G6 system user guide. Published online March 2020. Accessed July 16, 2020. https:\/\/s3-us-west-2.amazonaws.com\/dexcompdf\/G6-CGM-Users-Guide.pdf"},{"key":"bibr69-19322968211016480","unstructured":"Medtronic MiniMed. Medtronic guardian connect system user guide. Published online 2020. Accessed April 14, 2021. https:\/\/www.medtronicdiabetes.com\/sites\/default\/files\/library\/download-library\/user-guides\/Guardian-Connect-System-User-Guide.pdf"},{"key":"bibr70-19322968211016480","doi-asserted-by":"publisher","DOI":"10.4158\/EP15672.GL"},{"key":"bibr71-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0017"},{"key":"bibr72-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-00733-9"},{"key":"bibr73-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-017-0005-1"},{"key":"bibr74-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2196\/14956"},{"key":"bibr75-19322968211016480","doi-asserted-by":"crossref","unstructured":"Weinstock RS, Aleppo G, Bailey TS, et al. The Role of Blood Glucose Monitoring in Diabetes Management. American Diabetes Association; 2020. Accessed April 14, 2021. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK566165\/","DOI":"10.2337\/db2020-31"},{"key":"bibr76-19322968211016480","unstructured":"U.S. Food and Drug Administration. Proposed regulatory framework for modifications to artificial intelligence\/machine learning-based software as a medical device. Published online April 2019. Accessed April 14, 2021. https:\/\/www.fda.gov\/media\/122535\/download"},{"key":"bibr77-19322968211016480","unstructured":"U.S. Food and Drug Administration. Cybersecurity. Published online January 14, 2021. Accessed April 2, 2021. https:\/\/www.fda.gov\/medical-devices\/digital-health-center-excellence\/cybersecurity"},{"key":"bibr78-19322968211016480","unstructured":"U.S. Food and Drug Administration. Real-world evidence. FDA. Published November 24, 2020. Accessed April 14, 2021. https:\/\/www.fda.gov\/science-research\/science-and-research-special-topics\/real-world-evidence"},{"key":"bibr79-19322968211016480","unstructured":"U.S. Food and Drug Administration. COVID MyStudies application (app). FDA. Published May 29, 2020. Accessed April 14, 2021. https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/covid-mystudies-application-app"},{"key":"bibr80-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/BF01405730"},{"key":"bibr81-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30312-0"},{"key":"bibr82-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32000-6"},{"key":"bibr83-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820963630"},{"key":"bibr84-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2666"},{"key":"bibr85-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2018.0036"},{"key":"bibr86-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0483-z"},{"key":"bibr87-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0085"},{"key":"bibr88-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1136\/bmjnph-2020-000133"},{"key":"bibr89-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600"},{"key":"bibr90-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05027-0"},{"key":"bibr91-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.07.006"},{"key":"bibr92-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4946-6"},{"key":"bibr93-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817747886"},{"key":"bibr94-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db18-900-P"},{"key":"bibr95-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db18-353-OR"},{"key":"bibr96-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30368-X"},{"key":"bibr97-19322968211016480","unstructured":"Association of Diabetes Care & Education Specialists, Sanofi. ADCES and Sanofi National Diabetes survey results infographic. Published online 2020. Accessed March 25, 2021. https:\/\/www.diabeteseducator.org\/docs\/default-source\/practice\/educator-tools\/sanofi-survey-2020\/adces-national-diabetes-survey-results_infographic.pdf?sfvrsn=2"},{"key":"bibr98-19322968211016480","unstructured":"Registry\u2014T1D exchange. Accessed March 25, 2021. https:\/\/t1dexchange.org\/registry\/"},{"key":"bibr99-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1091"},{"key":"bibr100-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1922"},{"key":"bibr101-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2017.2677953"},{"key":"bibr102-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprocont.2019.05.017"},{"key":"bibr103-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300506"},{"key":"bibr104-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db20-231-OR"},{"key":"bibr105-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3003"},{"key":"bibr106-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30006-7"},{"key":"bibr107-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0330"},{"key":"bibr108-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0514-8"},{"key":"bibr109-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13767"},{"key":"bibr110-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1771"},{"key":"bibr111-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13205"},{"key":"bibr112-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13610"},{"key":"bibr113-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db17-890-1488"},{"key":"bibr114-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db17-890-1488"},{"key":"bibr115-19322968211016480","unstructured":"U.S. Food and Drug Administration. LYUMJEV. Published June 2020. Accessed April 15, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761109s000lbl.pdf"},{"key":"bibr116-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14100"},{"key":"bibr117-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14368"},{"key":"bibr118-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300627"},{"key":"bibr119-19322968211016480","unstructured":"Caffrey M. Could aiming insulin at the liver be an answer to using less? AJMC. Published September 2019. Accessed April 15, 2021. https:\/\/www.ajmc.com\/view\/could-aiming-insulin-at-the-liver-be-an-answer-to-using-less"},{"key":"bibr120-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db20-111-LB"},{"key":"bibr121-19322968211016480","unstructured":"Mannkind Corporation. Take control with Afrezza\n                      \u00ae\n                      . Afrezza. Accessed April 15, 2021. https:\/\/afrezza.com\/"},{"key":"bibr122-19322968211016480","unstructured":"Mannkind Corporation. Dosing & Titration. Afrezza (insulin human) inhalation powder. Published 2020. Accessed April 15, 2021. https:\/\/www.afrezzahcp.com\/dosing-and-titration"},{"key":"bibr123-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0200"},{"key":"bibr124-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00958-8"},{"key":"bibr125-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/0192623320960420"},{"key":"bibr126-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db20-236-OR"},{"key":"bibr127-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022474"},{"key":"bibr128-19322968211016480","first-page":"317","volume":"63","author":"Lingvay I","year":"2020","journal-title":"Diabetologia"},{"key":"bibr129-19322968211016480","first-page":"317","volume":"63","author":"Bajaj H","year":"2020","journal-title":"Diabetologia"},{"key":"bibr130-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500317"},{"key":"bibr131-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820930038"},{"key":"bibr132-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1267"},{"key":"bibr133-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817697329"},{"key":"bibr134-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0028"},{"key":"bibr135-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107680"},{"key":"bibr136-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700324"},{"key":"bibr137-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814532882"},{"key":"bibr138-19322968211016480","unstructured":"POCT05Ed2. Performance Metrics for Continuous Interstitial Glucose Monitoring. 2nd ed. Clinical & Laboratory Standards Institute. Accessed February 9, 2021. https:\/\/clsi.org\/standards\/products\/point-of-care-testing\/documents\/poct05\/"},{"key":"bibr139-19322968211016480","unstructured":"Clinical & Laboratory Standards Institute. CLSI guidelines. Accessed April 15, 2021. https:\/\/clsi.org\/"},{"key":"bibr140-19322968211016480","unstructured":"IFCC. Working group on continuous glucose monitoring (WG-CGM). Accessed April 15, 2021. https:\/\/www.ifcc.org\/ifcc-scientific-division\/sd-working-groups\/wg-cgm\/"},{"key":"bibr141-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.12.025"},{"key":"bibr142-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816662047"},{"key":"bibr143-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818812062"},{"key":"bibr144-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0105"},{"key":"bibr145-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820954163"},{"key":"bibr146-19322968211016480","unstructured":"Dexcom. Fact sheet for healthcare providers: use of Dexcom continuous glucose monitoring systems during the COVID-19 pandemic. Published April 3, 2020. Accessed July 29, 2020. https:\/\/www.dexcom.com\/hospitalfacts"},{"key":"bibr147-19322968211016480","unstructured":"Diabetes Technology Society. DTSec cybersecurity standard. Accessed April 15, 2021. https:\/\/www.diabetestechnology.org\/dtsec.shtml"},{"key":"bibr148-19322968211016480","unstructured":"Diabetes Technology Society. DTMoSt cybersecurity standard. Accessed April 15, 2021. https:\/\/www.diabetestechnology.org\/dtmost.shtml"},{"key":"bibr149-19322968211016480","unstructured":"Initiative RS Director of Global Marketing at the Founder Institute & Co-founder of the Female Founder. Only 3% of business investment goes to women, and that\u2019s a problem for everyone. Crunchbase. Published April 8, 2020. Accessed April 21, 2021. https:\/\/about.crunchbase.com\/blog\/business-investment-to-women\/"},{"key":"bibr150-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-45002-1_6"},{"key":"bibr151-19322968211016480","unstructured":"NPR.org. The Parkinson\u2019s doctor will video chat with you now. Accessed April 1, 2021. https:\/\/www.npr.org\/2011\/06\/27\/137089619\/the-parkinsons-doctor-will-video-chat-with-you-now"},{"key":"bibr152-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28296"},{"key":"bibr153-19322968211016480","unstructured":"Ron Poropatich MD. Regenerative medicine at the McGowan Institute. Accessed April 1, 2021. https:\/\/mirm-pitt.net\/our-people\/faculty-staff-bios\/ron-poropatich-md\/"},{"key":"bibr154-19322968211016480","unstructured":"SimSensei. Accessed April 1, 2021. https:\/\/ict.usc.edu\/prototypes\/simsensei\/"},{"key":"bibr155-19322968211016480","unstructured":"Farr C. Microsoft has an idea for using smart glasses to track your diet. CNBC. Published May 9, 2017. Accessed April 1, 2021. https:\/\/www.cnbc.com\/2017\/05\/09\/microsoft-patents-smart-glasses-for-diet-tracking-html"},{"key":"bibr156-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820951784"},{"key":"bibr157-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/0894439314547617"},{"key":"bibr158-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa221"},{"key":"bibr159-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.03.003"},{"key":"bibr160-19322968211016480","unstructured":"Participation of Women and Minorities\n                      . National Academies Press (US); 2015. Accessed April 16, 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK338149\/"},{"key":"bibr161-19322968211016480","unstructured":"Healthcare IT News. Women CEOs still rare in digital health startups, Rock Health says. Published July 25, 2018. Accessed April 16, 2021. https:\/\/www.healthcareitnews.com\/news\/women-ceos-still-rare-digital-health-startups-rock-health-says"},{"key":"bibr162-19322968211016480","unstructured":"Panio D. Creating LAIA: the feasibility of a woman-focused incubator & accelerator in Los Angeles. Published online March 2019. Accessed April 16, 2021. https:\/\/www.pressrelease.com\/files\/33\/cc\/d1619619dfd16da0b299f4e67765.pdf"},{"key":"bibr163-19322968211016480","unstructured":"Digitalundivided. ProjectDiane2018\u2014the state of Black & Latinxwomen founders. Published online 2018. Accessed April 16, 2021. https:\/\/www.projectdiane.com\/"},{"key":"bibr164-19322968211016480","unstructured":"JDRF. Type 1 diabetes facts. Accessed April 19, 2021. https:\/\/www.jdrf.org\/t1d-resources\/about\/facts\/"},{"key":"bibr165-19322968211016480","unstructured":"Saydah SH. Medication use and self-care practices in persons with diabetes. In: Cowie CC, Casagrande SS, Menke A, et al, eds. Diabetes in America. 3rd ed. National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018. Accessed April 19, 2021. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567996\/"},{"key":"bibr166-19322968211016480","unstructured":"National survey reveals people living with diabetes feel they are doing everything they can to manage their condition, yet believe more can be done. Accessed April 16, 2021. https:\/\/www.diabeteseducator.org\/news-and-publications\/press-releases\/press-releases\/2020\/10\/19\/national-survey-reveals-people-living-with-diabetes-feel-they-are-doing-everything-they-can-to-manage-their-condition-yet-believe-more-can-be-done"},{"key":"bibr167-19322968211016480","unstructured":"DIABNEXT. CLIPSULIN\u2014smart insulin pen for diabetes patients, connected to mobile app. Accessed April 16, 2021. https:\/\/www.diabnext.com\/clipsulin-c3\/"},{"key":"bibr168-19322968211016480","unstructured":"Medtronic Diabetes. Guardian connect InPen. Published November 12, 2020. Accessed April 19, 2021. https:\/\/www.medtronicdiabetes.com\/products\/cgm-and-smart-pen"},{"key":"bibr169-19322968211016480","unstructured":"Medtronic plc. Medtronic to acquire smart insulin pen company companion medical. GlobeNewswire News Room. Published August 11, 2020. Accessed April 16, 2021. https:\/\/www.globenewswire.com\/news-release\/2020\/08\/11\/2076475\/0\/en\/Medtronic-to-Acquire-Smart-Insulin-Pen-Company-Companion-Medical.html"},{"key":"bibr170-19322968211016480","unstructured":"Companion Medical. Inpen system healthcare professional instructions for use. Published online 2020. Accessed April 16, 2021. http:\/\/www.companionmedical.com\/guides\/inpen-hcp-ifu.pdf"},{"key":"bibr171-19322968211016480","unstructured":"Companion Medical. Companion medical InPen receives FDA clearance for expanded pediatric use. Cision PR Newswire. Published June 23, 2020. Accessed April 16, 2021. https:\/\/www.prnewswire.com\/news-releases\/companion-medical-inpen-receives-fda-clearance-for-expanded-pediatric-use-301081939.html"},{"key":"bibr172-19322968211016480","unstructured":"Companion Medical. InPen adds fixed dose and meal estimation options. Cision PR Newswire. Published April 8, 2020. Accessed April 16, 2021. https:\/\/www.prnewswire.com\/news-releases\/inpen-adds-fixed-dose-and-meal-estimation-options-301037339.html"},{"key":"bibr173-19322968211016480","unstructured":"Companion Medical. Companion medical announces CE mark of InPen\n                      TM\n                      system. Cision PR Newswire. Published July 19, 2018. Accessed April 16, 2021. https:\/\/www.prnewswire.com\/news-releases\/companion-medical-announces-ce-mark-of-inpen-system-300683872.html"},{"key":"bibr174-19322968211016480","unstructured":"Mallya Biocorp. Biocorp. Accessed April 16, 2021. https:\/\/biocorpsys.com\/en\/our-products\/connected-devices\/mallya\/"},{"key":"bibr175-19322968211016480","unstructured":"Kirsch D. Biocorp wins CE Mark for Mallya insulin pen sensor. Drug Delivery Business. Published June 14, 2019. Accessed April 16, 2021. https:\/\/www.drugdeliverybusiness.com\/biocorp-wins-ce-mark-for-mallya-insulin-pen-sensor\/"},{"key":"bibr176-19322968211016480","unstructured":"CONNECTED CARE: current platforms in development. Accessed April 16, 2021. https:\/\/www.lillymedical.com\/en-us\/answers\/connected-care-current-platforms-in-development-77242?hcpToken=A12DSa08bhrd123gg8&channel=AE"},{"key":"bibr177-19322968211016480","unstructured":"Lilly Investors. Lilly to integrate Dexcom CGM into personalized diabetes management system. Published December 16, 2019. Accessed April 16, 2021. https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lilly-integrate-dexcom-cgm-personalized-diabetes-management"},{"key":"bibr178-19322968211016480","unstructured":"NovoPen\n                      \u00ae\n                      6. Novo nordisk. Accessed April 16, 2021. https:\/\/www.novonordisk.com\/our-products\/smart-pens\/novopen-6.html"},{"key":"bibr179-19322968211016480","unstructured":"Bigfoot biomedical. Accessed April 16, 2021. https:\/\/www.bigfootbiomedical.com"},{"key":"bibr180-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1728"},{"key":"bibr181-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13105"},{"key":"bibr182-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.2525.abstracts"},{"key":"bibr183-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0517"},{"key":"bibr184-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1980.sp013190"},{"key":"bibr185-19322968211016480","unstructured":"PercuSense. Continuous monitoring. PercuSense, United States. Accessed December 15, 2020. https:\/\/www.percusense.com"},{"key":"bibr186-19322968211016480","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00360"},{"key":"bibr187-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0509"},{"key":"bibr188-19322968211016480","unstructured":"Vogels EA. About one-in-five Americans use a smart watch or fitness tracker. Fact Tank. Published January 9, 2020. Accessed April 19, 2021. https:\/\/www.pewresearch.org\/fact-tank\/2020\/01\/09\/about-one-in-five-americans-use-a-smart-watch-or-fitness-tracker\/"},{"key":"bibr189-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2196\/11486"},{"key":"bibr190-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819883340"},{"key":"bibr191-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23302-9"},{"key":"bibr192-19322968211016480","unstructured":"Joseph JI, Helmond NV, Torjman MC, Devine DL, Dicciani NK, Loeum C. Acoustic sensor and ventilation monitoring system. Published online November 24, 2020. Accessed April 19, 2021. https:\/\/patents.google.com\/patent\/US10842416B2\/en?oq=Patent+Grant+10842416"},{"key":"bibr193-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201400264"},{"key":"bibr194-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0175"},{"key":"bibr195-19322968211016480","volume":"48","author":"Crothall K","year":"1999","journal-title":"Diabetes"},{"key":"bibr196-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1109\/IEMBS.2011.6090122"},{"key":"bibr197-19322968211016480","unstructured":"Hipszer B, Alagoz A, Park J-W, Gottlieb R, Joshi R, Joseph J. Evaluation of a Subcutaneous Hospital Sensor in Diabetic Volunteers Using a Standardized Glucose Clamp Protocol. Presented at the: The Anesthesiology Annual Meeting; October 16, 2011. Accessed May 7, 2021. http:\/\/www.asaabstracts.com\/strands\/asaabstracts\/abstract.htm?year=2011&index=8&absnum=6104"},{"key":"bibr198-19322968211016480","unstructured":"Chockalingam N. Preventing a million diabetic foot amputations. The Conversation. Accessed April 19, 2021. http:\/\/theconversation.com\/preventing-a-million-diabetic-foot-amputations-90257"},{"issue":"6","key":"bibr199-19322968211016480","first-page":"1325","volume":"57","author":"Armstrong DG","year":"1998","journal-title":"Am Fam Physician"},{"key":"bibr200-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820930290"},{"key":"bibr201-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2294"},{"key":"bibr202-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817709022"},{"key":"bibr203-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-817485-2.00013-4"},{"key":"bibr204-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3239"},{"key":"bibr205-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2019.02.041"},{"key":"bibr206-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2215"},{"key":"bibr207-19322968211016480","unstructured":"Hypo-RESOLVE. Concept & approach. Accessed April 1, 2021. https:\/\/hypo-resolve.eu\/concept-and-approach"},{"key":"bibr208-19322968211016480","unstructured":"King\u2019s College London. Hypo-METRICS: Hypoglycaemia\u2014Measurement, ThResholds and ImpaCtS a Clinical Study to Determine the Optimal Threshold and Duration of Low Interstitial Glucose Events That Have an Impact on Patient Experienced Hypoglycaemia, Quality of Life and Health Economic Outcomes. clinicaltrials.gov; 2020. Accessed March 31, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04304963"},{"key":"bibr209-19322968211016480","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.2525.abstracts"},{"key":"bibr210-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db20-14-LB"},{"key":"bibr211-19322968211016480","doi-asserted-by":"publisher","DOI":"10.2337\/db20-38-LB"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968211016480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968211016480","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968211016480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:11:02Z","timestamp":1777399862000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968211016480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":211,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1177\/19322968211016480"],"URL":"https:\/\/doi.org\/10.1177\/19322968211016480","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}